Abstract
The CD8 coreceptor of cytotoxic T lymphocytes binds to a conserved region of major histocompatibility complex class I molecules during recognition of peptide-major histocompatibility complex (MHC) class I antigens on the surface of target cells. This event is central to the activation of cytotoxic T lymphocyte (CTL) effector functions. The contribution of the MHC complex class I light chain, beta(2)-microglobulin, to CD8alphaalpha binding is relatively small and is mediated mainly through the lysine residue at position 58. Despite this, using molecular modeling, we predict that its mutation should have a dramatic effect on CD8alphaalpha binding. The predictions are confirmed using surface plasmon resonance binding studies and human CTL activation assays. Surprisingly, the charge-reversing mutation, Lys(58) --> Glu, enhances beta(2)m-MHC class I heavy chain interactions. This mutation also significantly reduces CD8alphaalpha binding and is a potent antagonist of CTL activation. These results suggest a novel approach to CTL-specific therapeutic immunosuppression.
References
Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·D N GarbocziD C Wiley
Oct 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·P A MossJ I Bell
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·K L RockB Benacerraf
Jul 5, 1989·Journal of Molecular Biology·C L Brooks, M Karplus
Aug 11, 1987·Biochemistry·A T BrüngerM Karplus
Jan 1, 1995·The Journal of Experimental Medicine·P J LehnerL K Borysiewicz
Jun 5, 1997·Nature·G F GaoB K Jakobsen
Mar 25, 1998·Current Biology : CB·D A PriceR E Phillips
Oct 17, 1998·The Journal of Biological Chemistry·M J ShieldsR K Ribaudo
Jan 15, 1999·Analytical Biochemistry·C A O'callaghanJ I Bell
Apr 15, 1999·Nature Medicine·A K SewellB K Jakobsen
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Dec 14, 1999·Protein Science : a Publication of the Protein Society·B E WillcoxB K Jakobsen
Aug 10, 2000·Molecular Biotechnology·C C Broder, P L Earl
Dec 19, 2000·Journal of Virology·T TolfvenstamP Klenerman
May 24, 2001·Immunity·X N XuG R Screaton
Jul 5, 2001·The Journal of Biological Chemistry·M A PurbhooA K Sewell
Apr 30, 1998·The Journal of Physical Chemistry. B·A D MacKerellM Karplus
Citations
Jul 23, 2002·Trends in Immunology·George F GaoJohn I Bell
Apr 20, 2005·The Journal of Biological Chemistry·Linda WooldridgeAndrew K Sewell
May 31, 2007·The Journal of Experimental Medicine·Melissa L PrecopioRichard A Koup
Jan 21, 2004·Journal of Molecular Recognition : JMR·Rebecca L Rich, David G Myszka
Jun 2, 2007·The Journal of Biological Chemistry·Bruno LaugelAndrew K Sewell
Apr 17, 2003·The Journal of Biological Chemistry·Sarah L HutchinsonAndrew K Sewell
Nov 28, 2002·The Journal of Biological Chemistry·Dawn M HillSteven Kozlowski
Oct 7, 2008·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Pratip K ChattopadhyayDavid A Price
Dec 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Linda WooldridgeAndy K Sewell
Dec 30, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Giorgio ParmianiMario Santinami